Related Experiment Video
Updated: Jul 13, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
Published on: December 8, 2023
[Cell therapy for inherited diseases of the hematopoietic system]
Marina Cavazzana-Calvo1, Liliane Dal-Cortivo, Isabelle André-Schmutz
1Inserm, U768, Paris & université René-Descartes (Paris-5), hôpital Necker-Enfants-Malades, 149, rue de Sevres, 75743 Paris cedex 15, France. m.cavazzana@nck.aphp.fr
Abstract:
Cell therapy was born in 1968 with the first allogeneic transplantation of hematopoietic stem cells for two immune deficiency disorders: the Wiskott-Aldrich syndrome and the Severe Combined ImmunoDeficiency (SCID). From this pioneering experience, thousands of patients affected with inherited or acquired diseases of the hematopoietic system have benefited from this therapeutic approach. Unfortunately, immunologic obstacles, represented by the compatibility in the major histocompatibility HLA system, still dictate today important limitations for a larger therapeutic utilization of hematopoietic stem cells (HSC). In this review, we have summarized the difficulties and the scientific advances leading us to improve the clinical results; the therapeutic research's track for primary immunodeficiencies is also discussed.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Regulation of Hematopoietic Stem Cells
Hematopoiesis
Multipotency of Hematopoietic Stem Cells
Stem Cell Culture

